HEALEY ALS Platform Trial Regimen I enrolment completed - Topline results for NUZ-001 accelerated to Q2 CY2027
- Written by PR Newswire Asia - News Pronto RSS
- 250 participants enrolled in less than five months from first participant dosing, representing the fastest site activation and enrolment in the HEALEY ALS Platform Trial so far
- Anticipated topline efficacy and safety results for NUZ-001 now expected in late Q2 CY2027
- Completion of recruitment materially de-risks execution of Neurizon's lead...